Molecules/DROZITUMAB

DROZITUMAB

Molecular Identity

AntibodyPhase 2

Mechanism of action: Tumor necrosis factor receptor superfamily member 10B agonist

Molecular Formula

0.00

Molecular Weight

g/mol

ANTI-DR5ANTI-DR5 RHUMAB-DR5DROZITUMABPRO-95780RHUMAB DR5RHUMAB-DR5USP MAB 003, MONOCLONAL IGG1

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to DROZITUMAB

Loading drug network...